long term side effects of glp-1 receptor agonists Adverse Full article: Managing the gastrointestinal
Description
29 The randomized, double-blind study enrolled 1,864 participants with a mean baseline A1C of 8.3% and BMI of 32.5
Who Should Be Careful With Weight Loss Medications
& Altman, D
Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: Mechanistic insights and therapeutic implications
The RR is lowest at 3 months 0.43 (95% CI: 0.28, 0.67
However, continuous research and vigilant monitoring are essential to optimize their safe use [55] [56], particularly as these medications are used in broader populations for longer durations
